Anti-Human/Mouse/Rat Alpha Smooth Muscle (αSM) Actin (1A4)- Purified

Leinco Technologies
Product Code: LEI-A460
Product Group: Primary Antibodies
CodeSizePrice
LEI-A460-25ug25 ug£175.00
Quantity:
LEI-A460-200ug200 ug£311.00
Quantity:
LEI-A460-2mg2 mg£1,014.00
Quantity:
LEI-A460-10mg10 mg£2,263.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Antibody Isotype: Mouse IgG2a k
Antibody Clonality: Monoclonal
Antibody Clone: 1A4
Regulatory Status: RUO
Target Species:
  • Human
  • Mouse
  • Rat
Applications:
  • Flow Cytometry
  • Functional Study
  • Immunofluorescence (IF)
  • Immunohistochemistry (IHC)
  • Immunohistochemistry- Paraffin Embedded (IHC-P)
  • Immunoprecipitation (IP)
  • Western Blot (WB)
Shipping:
2 - 8°C Wet Ice
Storage:
This antibody may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.

Further Information

Antigen Distribution:
Alpha-smooth muscle actin (SMA) is expressed by myofibroblasts and is the actin isoform typical of vascular smooth muscle cells. SMA is incorporated into stress fibers and focal adhesions and is also expressed by granulation tissue fibroblasts of healing wounds. Additionally, SMA expression is activated during the early stages of embryonic cardiovascular development. Astrocytes can also express SMA in culture. SMA is highly expressed in cancer-associated fibroblasts.
Concentration:
0.5 mg/ml
Conjugate/Tag/Label:
Purified No Carrier Protein
Format:
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added.
Formulation:
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added.
Immunogen:
N-terminal synthetic peptide corresponding to Human alpha smooth muscle actin.
Long Description:
Myofibroblasts are specialized connective tissue fibroblasts that use actin-based motors to generate contractile forces that are applied to extracellular matrix adhesion receptors 1. Alpha-smooth muscle actin (SMA) is a tissue specific actin isoform involved in myofibroblast differentiation, focal adhesion maturation, actin polymerization, tractional remodeling of the extracellular matrix, and the generation and transmission of mechanical forces in connective tissue, i.e., mechanotransduction. These physical forces are important for wound healing, joint and ligament remodeling due to injury or pregnancy, and the maintenance of tissue structure in the urinary bladder. SMA facilitates the generation of contractile forces in myofibroblasts and may contribute to scar formation and fibrocontractive diseases 1. Additionally, cancer-associated fibroblasts (CAF) play key roles in the tumor microenvironment, affecting tumor development, metabolism, and migration 2. SMA is highly expressed in CAFs and is widely used as a marker to identify CAF populations. However, SMA cannot be used for flow-sorting CAF populations for further functional studies because of its intracellular localization. 1A4 was produced using a synthetic decapeptide as immunogen, consisting of the NH2-terminal peptide of SMA coupled to BSA and a keyhole limpet hemocyanin (Ac-Glu(OBut)-Glu(OBut)-Glu(OBut)-Asp(OBut)-Ser(But)-Thr(But)-Ala-Leu-Val-Cys(Acm)-NHEt) 3. BALB/c mice were immunized and spleen cells were fused with Sp2/0 myeloma cells. Hybridomas were screened by ELISA against bovine aortic actin and further tested by immunofluorescence in chicken gizzard.
NCBI Gene:
59
Target:
α-Smooth Muscle Actin (SMA)

References

1. Wang J, Zohar R, McCulloch CA. Exp Cell Res. 312(3):205-214. 2006. 2. Nurmik M, Ullmann P, Rodriguez F, et al. Int J Cancer. 146(4):895-905. 2020. 3. Skalli O, Ropraz P, Trzeciak A, et al. J Cell Biol. 103(6 Pt 2):2787-2796. 1986. 4. Sch?rch W, Skalli O, Seemayer TA, et al. Am J Pathol. 128(1):91-103. 1987. 5. Rudy DE, Yatskievych TA, Antin PB, et al. Dev Dyn. 221(1):61-71. 2001. 6. Franke WW, Moll R. Differentiation. 36(2):145-163. 1987. 7. Chang CY, Chiou PP, Chen WJ, et al. Res Vet Sci. 88(2):285-293. 2010. 8. Lavaud S, Poirier B, Mandet C, et al. Am J Physiol Renal Physiol. 280(4):F683-694. 2001. 9. Li Y, Pan Z, Ji Y, et al. Eur Heart J. 23(7):567-573. 2002. 10. Cinel L, D??mez D, Nabaei SH, et al. Acta Obstet Gynecol Scand.